Clinical efficacy and safety: blood products (including biotech alternatives)

  • Email
  • Help

The European Medicines Agency’s scientific guidelines on the clinical evaluation of blood products help medicine developers prepare marketing authorisation applications for human medicines.

If you have comments on a document which is open for consultation, use the form for submission of comments on scientific guidelines.

Please submit your comments to the following email address: bpwpsecretariat@ema.europa.eu.

For a complete list of scientific guidelines currently open for consultation, see Public consultations.

Human coagulation factor VIII & human coagulation factor IX 

Guidelines


Reflection papers


Other coagulation factors

Guidelines


Normal immunoglobulins

Guidelines


Specific immunoglobulins

Guidelines


Others

Guidelines


General

Guidelines

How helpful is this page?

Average rating:

 Based on 2 ratings

Add your rating:

See all ratings
0 ratings
0 ratings
0 ratings
0 ratings
2 ratings
    

Tell us more

Related content